91AV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

RSC Medicinal 91AV Desktop Seminar Series

30 September 2020 17:00-18:20, Online, United Kingdom


Introduction

RSC Desktop Seminars are a new initiative from the 91AV to bring cutting-edge research directly to you! Now, more than ever, there is a crucial need for sharing research, and each seminar series will feature a range of speakers on a related topic.
 
Join RSC Medicinal 91AV Associate Editor Professor Sylvie Garneau-Tsodikova, (University of Kentucky) and the 2020 RSC Medicinal 91AV Emerging Investigator Lectureship recipient Dr. Chandradhish Ghosh (Max Planck Institute of Colloids and Interfaces), as they kick off the RSC Medicinal 91AV Desktop Seminar Series. Introductions will be given by RSC Medicinal 91AV Executive Editor, Dr. Katie Lim, and the webinar will be hosted by Dr. Jennifer Lee.

This 80-minute seminar will allow researchers of all professional levels to connect, share ideas, and ask questions. Be sure to register for the free seminar series today!

Speakers

Dr. Chandradhish Ghosh
"Fantastic bugs and how to kill them"

Professor Sylvie Garneau-Tsodikova
"
Infectious disease research/publishing in time of a pandemic"

Programme

17:00 BST (12:00 PM EDT) – Welcome & introduction
17:05 BST (12:05 PM EDT) – Dr. Chandradhish Ghosh (Fantastic bugs and how to kill them)
17:30 BST (12:30 PM EDT) – Q&A with Dr. Chandradhish Ghosh
17:40 BST (12:40 PM EDT) – Professor Sylvie Garneau-Tsodikova (Infectious disease research/publishing in time of a pandemic)
18:00 BST (1:00 PM EDT) – Q&A with Professor Sylvie Garneau-Tsodikova
18:10 BST (1:10 PM EDT) – Closing remarks

Speakers
Dr. Chandradhish Ghosh, Max Planck Institute of Colloids and Interfaces, Germany

Dr. Chandradhish Ghosh performed his doctoral studies at Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, under the supervision of Prof. Jayanta Haldar, after first earning his MSc in 91AV at the University of Delhi. Since 2017, he has been working at the Max Planck Institute for Colloids and Interfaces, in the group of Prof. Peter H. Seeberger. His current work focusses on targeting neglected tropical diseases using glyconanomaterials.

Dr. Chandradhish Ghosh performed his doctoral studies at Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, under the supervision of Prof. Jayanta Haldar, after first earning his MSc in 91AV at the University of Delhi. Since 2017, he has been working at the Max Planck Institute for Colloids and Interfaces, in the group of Prof. Peter H. Seeberger. His current work focusses on targeting neglected tropical diseases using glyconanomaterials.
 
His doctoral work on membrane-active small molecules against drug-resistant pathogens has led to an anti-Ebola drug candidate. He has contributed to the sum of knowledge in the field by the publication of several highly cited reviews. He has won several awards, including the prestigious Gandhian Young Technological Innovation Award in 2015.
 


Professor Sylvie Garneau-Tsodikova, University of Kentucky, United States

Sylvie Garneau-Tsodikova obtained her Ph.D. in 91AV in 2003 from the University of Alberta (Prof. John C. Vederas). She then pursued her postdoctoral studies with Prof. Christopher T. Walsh at Harvard Medical School. In 2006, Sylvie joined the University of Michigan as the John G. Searle Assistant Professor of Medicinal 91AV at the College of Pharmacy and the Life Sciences Institute. In 2013, she relocated to the University of Kentucky as an Associate Professor of Pharmaceutical Sciences with tenure at the College of Pharmacy, where she is now the Patrick P. DeLuca Pharmaceutical Technology Professor and Assistant Dean for Research. Her work focuses on understanding and combating bacterial and fungal resistance. Her expertise is in medicinal chemistry and her group also works at the interface of biochemistry and microcrobiology.
 
She is an Associate Editor for RSC Medicinal 91AV since the inception of the journal in 2010.  She is the recipient of numerous awards including the Vahlteich Research Award and NSF CAREER Award. She has published >150 manuscripts and has given >90 invited talks and plenary lectures on her work worldwide. As a result of her passion/work for outreach, she is an AAAS Leshner Fellow for public engagement as well as an AAAS/Lyda Hill IF/THEN ambassador. She is striving and working hard for equality and inclusivity in science.



Venue
Go To Webinar

Go To Webinar, Online, United Kingdom

Organised by
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*